OpenVSafe by OpenVAERS
Search V-safe

FJN-10393-95433

2 vaccinations 3 coded responses 13 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
194 / PA
Registered
2021-04-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Registered in v-safe
  2. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-08
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-15
    Survey response — day 14, dose 1
    MedDRA: Apathy, Attention deficit hyperactivity disorder, Condition aggravated, Depression, Fatigue, Pain in extremity, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Extreme fatigue, lower leg aches, apathy, worsening of neurological/psychological symptoms of low grade depression and adhd . Neurological/psychological symptoms began before last check in but were forgotten about while completing daily check ins.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-22
    Dose 2 — Pfizer-BioNTech
  8. 2021-04-22
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  9. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Memory impairment — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Forgetfulness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  11. 2021-05-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-16
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-31
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-07-22
    Survey response — 3 months, dose 2
    MedDRA: Condition aggravated, Gait disturbance, Hypersomnia, Mental fatigue, Pre-existing disease, Temperature intolerance — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Need for longer sleep, difficulty waking in morning, increased adhd symptoms, faster mental fatigue, lower heat (weather) tolerance. [Note: general health is overall better now because of successful diet and exercise changes in the last month]
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-07-22
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  16. 2021-07-28
  17. 2021-10-23
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-04-22
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-22Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-15

Symptoms: Extreme fatigue, lower leg aches, apathy, worsening of neurological/psychological symptoms of low grade depression and adhd . Neurological/psychological symptoms began before last check in but were forgotten about while completing daily check ins.

Release 7 — days 1–6 daily, dose 2

2021-04-23

Systemic reaction (other): Forgetfulness

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: Need for longer sleep, difficulty waking in morning, increased adhd symptoms, faster mental fatigue, lower heat (weather) tolerance. [Note: general health is overall better now because of successful diet and exercise changes in the last month]

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDApathy ✓ ✓ ✓
SDAttention deficit hyperactivity disorder ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDGait disturbance · · ✓
SDHypersomnia · · ✓
SDMental fatigue · · ✓
SDPain in extremity ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDTemperature intolerance · · ✓
SROMemory impairment ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release